Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 439

Results For "MIT"

5636 News Found

CytoSMART introduces ML algorithm for organoid analysis
Digitisation | June 16, 2022

CytoSMART introduces ML algorithm for organoid analysis

The innovative software module is designed to meet growing scientific demand from researchers and drug developers


Piramal Pharma expands API capabilities at Digwal
News | June 15, 2022

Piramal Pharma expands API capabilities at Digwal

Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies


Dr. Reddy's Lab launches sorafenib tablets in US
News | June 15, 2022

Dr. Reddy's Lab launches sorafenib tablets in US

Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.


Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
Public Health | June 15, 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa

This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.


Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate
News | June 15, 2022

Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate

Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.


InfuSystem and Ventis ink sales agreement for pain management
News | June 15, 2022

InfuSystem and Ventis ink sales agreement for pain management

The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management


CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics
News | June 15, 2022

CCI approves sale of biosimilars portfolio of Viatris to Biocon Biologics

The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics


Dr. Bharati Pravin Pawar launches Intensified Diarrhoea Control Fortnight – 2022
News | June 14, 2022

Dr. Bharati Pravin Pawar launches Intensified Diarrhoea Control Fortnight – 2022

The IDCF programme is being implemented from 13th June to 27th June, 2022 in the states/UTs and the goal is to attain zero child deaths due to childhood diarrhoea


Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants
News | June 14, 2022

Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants

Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile


Alembic receives USFDA tentative approval for Dasatinib tablets
Drug Approval | June 12, 2022

Alembic receives USFDA tentative approval for Dasatinib tablets

Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive